Anti-Dupilumab Neutralizing Recombinant Antibody (SAA2182) (AB732013)

Datasheet Share product Copy info

Price(USD): $

Spec:

20ug
50ug
100ug

Number:

Overview
Images
References
Datasheet

Overview

Catalog No.

AB732013

Description

Anti-Dupilumab Neutralizing Antibody (SAA2182) [SAA2182] (AB732013) is a rabbit monoclonal antibody in ELISA, Neutralization.

Highlights

●Rabbit Monoclonal — High specificity, affinity, and excellent lot-to-lot consistency.

Applications

ELISA, Neutralization

Host species

Rabbit

Isotype

IgG

Clone ID

SAA2182

Clonality

Monoclonal

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

CAS: 1190264-60-8

RRID

Anti-Dupilumab Neutralizing Antibody (SAA2182) (abinScience Cat# AB732013, RRID:AB_3729583)

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information

Application	Dilution
ELISA	1:2000-1:20000

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Note

For research use only.

Images

SDS-PAGE

SDS-PAGE for Anti-Dupilumab Neutralizing Antibody (SAA2182)

References

Datasheet

Anti-Dupilumab Neutralizing Recombinant Antibody (SAA2182).pdf

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Recombinant Proteins

Antibodies

Assay Kits

Anti-Dupilumab Neutralizing Recombinant Antibody (SAA2182) (AB732013)

Overview

Images

References

Datasheet

Quick access

Contact Us